ReviewViruses2024

Research Progress on Spike-Dependent SARS-CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of Spike.

Matthew R Freidel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.